Home > Protocol Summaries: Compounds > GSK1292263

Protocol Summaries: GSK1292263

Protocol Summaries for GSK1292263
GSK
Study ID		 Phase Title Status
111596 Phase 1 A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin Completed
111598 Phase 2 A study in type 2 diabetic subjects of single and multiple doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound Completed
113132 Phase 2 A study in type 2 diabetic subjects on stable metformin therapy to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of co-administering single and multiple oral doses of GSK1292263 Completed
113506 phase 1 A study to investigate the interaction of GSK1292263 with rosuvastatin and simvastatin in healthy subjects Completed

Filter list by: